Assignee
MOGAM BIOTECH RES INST
KR·19 granted patents·10 pending applications·646 citations·filing 1994–2014
Top patents by PatentIndex Score
29 records- 0195US6589548B1Controlled drug delivery system using the conjugation of drug to biodegradable polyesterMOGAM BIOTECH RES INST·Filed 1999·Granted Jul 8, 2003·467 cites·4 claims
- 0291US9493745B2Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the sameMOGAM BIOTECH RES INST·Filed 2014·Granted Nov 15, 2016·10 cites·11 claims
- 0390US7422874B2Expression vector for animal cellMOGAM BIOTECH RES INST·Filed 2001·Granted Sep 9, 2008·48 cites·5 claims
- 0487US7785875B2Polynucleotide encoding HCV epitopes which can bind to various HLA supertypes, immunogenic composition comprising same and method of inducing an HCV-specific immune response using sameMOGAM BIOTECH RES INST·Filed 2008·Granted Aug 31, 2010·11 cites·15 claims
- 0579US7285277B2Anticancer agentMOGAM BIOTECH RES INST·Filed 2005·Granted Oct 23, 2007·3 cites·18 claims
- 0679US7163698B2Controlled drug delivery system using the conjugation of drug to biodegradable polyesterMOGAM BIOTECH RES INST·Filed 2003·Granted Jan 16, 2007·10 cites·18 claims
- 0774US5840542AMethod for manufacture of proinsulin with high export yieldMOGAM BIOTECH RES INST·Filed 1995·Granted Nov 24, 1998·29 cites·4 claims
- 0873US8685409B2Influenza T-cell immunization against diverse influenza A virusesMOGAM BIOTECH RES INST·Filed 2012·Granted Apr 1, 2014·3 cites·10 claims
- 0965US7118905B2Nucleic acid encoding angiogenesis inhibitorMOGAM BIOTECH RES INST·Filed 2004·Granted Oct 10, 2006·2 cites·20 claims
- 1060US6140363AUse of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of SH2-mediated processesMOGAM BIOTECH RES INST·Filed 1999·Granted Oct 31, 2000·24 cites·20 claims
- 1157US6743428B1Angiogenesis inhibitorMOGAM BIOTECH RES INST·Filed 1999·Granted Jun 1, 2004·12 cites·18 claims
- 1254US2010063132A1Small interfering rna and pharmaceutical composition for treatment of hepatitis b comprising the sameMOGAM BIOTECH RES INST·Filed 2009·Application pending·0 cites
- 1353US2011129872A1Method for a production of a recombinant protein using yeast co-expression systemMOGAM BIOTECH RES INST·Filed 2009·Application pending·0 cites
- 1451US6500647B1Recombinant expression vector of human parathyroid hormoneMOGAM BIOTECH RES INST·Filed 1998·Granted Dec 31, 2002·11 cites·14 claims
- 1551US5889148AAntibiotic peptidesMOGAM BIOTECH RES INST·Filed 1996·Granted Mar 30, 1999·9 cites·2 claims
- 1650US7858361B2Transformed Saccharomyces cerevisiae and method for mass-production of LK8 protein using the sameMOGAM BIOTECH RES INST·Filed 2005·Granted Dec 28, 2010·0 cites·1 claims
- 1746US2008138394A1Composite For Liver-Specific Delivery and Release of Therapeutic Nucleic Acids or DrugsMOGAM BIOTECH RES INST·Filed 2007·Application pending·0 cites
- 1846US2010003742A1Method for reducing fucose contents of recombinant proteinsMOGAM BIOTECH RES INST·Filed 2009·Application pending·0 cites
- 1945US2011008885A1Linear double-stranded rna molecule interfering with different target genesMOGAM BIOTECH RES INST·Filed 2008·Application pending·0 cites
- 2043US2008096839A1Small Interfering Rna and Pharmaceutical Composition for Treatment of Hepatitis B Comprising the SameMOGAM BIOTECH RES INST·Filed 2006·Application pending·0 cites
- 2142US2010209491A1Method for enhancing serum stability and lowering immune response of sirna down-regulating gene expression of hbv or hcvMOGAM BIOTECH RES INST·Filed 2008·Application pending·0 cites
- 2241US2010196370A1Fusion protein of immunoglobulin fc and human apolipoprotein(a) kringle fragmentMOGAM BIOTECH RES INST·Filed 2007·Application pending·0 cites
- 2341US2002151683A1Liposomes comprising peptide antigens derived from X protein of hepatitis B virusMOGAM BIOTECH RES INST·Filed 2001·Application pending·0 cites
- 2438US2009318531A1Small Interfering RNA Specific For HCV And Therapeutic Agent For Hepatitis C Comprising The SameMOGAM BIOTECH RES INST·Filed 2006·Application pending·0 cites
- 2531US5821106ACDNA of direct-acting fibrinolytic serine proteaseMOGAM BIOTECH RES INST·Filed 1996·Granted Oct 13, 1998·1 cites·4 claims
- 2630US6380359B1Liposomes comprising peptide antigens derived from X protein of hepatitis B virusMOGAM BIOTECH RES INST·Filed 1998·Granted Apr 30, 2002·2 cites·2 claims
- 2729US5635473AInhibitor of hepatitis B virus replicationMOGAM BIOTECH RES INST·Filed 1994·Granted Jun 3, 1997·1 cites·3 claims
- 2828US5985609AProcess for preparing hepatitis C virus envelope glycoproteinsMOGAM BIOTECH RES INST·Filed 1994·Granted Nov 16, 1999·3 cites·6 claims
- 2925US7722887B1Detoxified mutants of escherichia coli heat-labile enterotoxinMOGAM BIOTECH RES INST·Filed 1999·Granted May 25, 2010·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when MOGAM BIOTECH RES INST files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →